If youre bullish on oil, then Continental Resources (CLR) is the stock for you. I believe the company will likely significantly grow its earnings in 2018 due to higher realized prices and around 20% production growth. Meanwhile the company, which burned cash flows in 2017, will likely report str
Related SPY Marty Fridson: High-Yield Bond Investors Should 'Overweight' U.S. Compared to Europe Dolan: Yellen To The Rescue Markets Are Missing The Point (Seeking Alpha)
Related S&P 500 Futures In A Freefall Jim Cramer Says These 6 Things Need To Happen Before The Market Can Bottom ....More>>>
June 5, 2017: Markets opened lower Monday following a report that several Middle East oil producing nations have cut ties with Qatar due to that country’s support for terrorism. The energy sector ended up being the best performer for the day, but that was not enough to offset poor performers like the utilities and materials sectors. WTI crude oil for July delivery settled at $47.40 a barrel,....More>>>
The Federal Reserve raised its target of the federal-funds rate, the interest rate banks charge each other for overnight loans, by a quarter point to a range of 0.75% to 1%, and thats great news for Warren Buffetts Berkshire Hathaway (BRK.B) and its shareholders. As a bondholder, owner of insurance companies and an investor in big banks, Berkshire profits from rising interest rates in a number....More>>>
Oil prices hit a 10-year low in January 2016, but since then they rose 47%. That means the top oil stocks of 2016 saw huge returns.
To give investors an overview of how well oil stocks did in 2016, Money Morning made a list of thetop oil stocks of 2016. To make our list of the top oil stocks, we looked at companies with biggest stock price growth and market cap of at least $1 billion.
Money Morning Director of Technology & Venture Capital Research Michael Robinson is still a big fan of Bitcoin and many of the other cryptocurrencies out there. But he acknowledges that they are not for everyone.
Shares of Kura Oncology (KURA) have risen by more than 90% since I presented the idea to readers in September of last year. The stock has climbed 38% since my update piece published in late November in which I stated my expectations of continued upside due to multiple clinical catalysts in 2018